Quantumcyte Revenue
Biotechnology Research • 
Singapore, Singapore, Singapore • 1-10 Employees
$
Quantumcyte revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Quantumcyte
Lynda Low
Vice President Asia/ GM ASEAN
Company overview
| Headquarters | Singapore, Singapore, Singapore |
| NAICS | 541714 |
| Keywords | Biotechnology, Pathology, Diagnostics, Oncology, Microdissection |
| Founded | 2021 |
| Employees | 1-10 |
About Quantumcyte
Pioneering next generation automated Micro-dissection Pathology through our highly advanced Cytomask platform. Combining patented science & technology, Cytomask platform delivers far superior diagnostic results especially for cancer patients. With pure and precise results, we open up pathways to bring about breakthroughs in cancer diagnosis & personalised treatments.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
Quantumcyte has never raised funding before.
Spain
Canada
United States
Frequently asked questions
Quantumcyte is located in Singapore, Singapore, SG.
Quantumcyte generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Quantumcyte has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Quantumcyte was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.
Quantumcyte has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
